Lymphoma Research Foundation
Income Statement
Fiscal Year Start:
Jul 1
Revenues in 2024
$13,925,738
Contributions
46%
Program Services
31%
Fundraising Events
16%
Investments
6%
Other
1%
Government Grants
0%
Membership Dues
0%
Expenses in 2024
$13,429,805
Salaries & Benefits
30%
Grants
26%
Other
16%
Fees to Service Providers
15%
Offices, Occupancy & IT
8%
Advertising & Promotion
4%
Depreciation
<1%
Benefits to Members
0%
Interest
0%
Revenues
2023
2024
Change
Contributions
$9,856,711
$6,462,482
-34%
Government Grants
$0
$0
-
Fundraising Events
$2,163,923
$2,186,116
+1%
Program Services
$4,214,232
$4,272,000
+1%
Membership Dues
$0
$0
-
Investments
$312,785
$844,153
+170%
Other
$19,305
$160,987
+734%
Total Revenues
$16,566,956
$13,925,738
-16%
Expenses
2023
2024
Change
Grants
$5,530,100
$3,514,100
-36%
Benefits to Members
$0
$0
-
Salaries & Benefits
$4,043,590
$4,017,428
-1%
Fees to Service Providers
$1,195,123
$2,047,383
+71%
Advertising & Promotion
$639,431
$582,420
-9%
Offices, Occupancy & IT
$945,619
$1,064,490
+13%
Interest
$0
$0
-
Depreciation
$43,265
$26,507
-39%
Other
$1,558,467
$2,177,477
+40%
Total Expenses
$13,955,595
$13,429,805
-4%
Net income
2023
2024
Change
Net income
+$2,611,361
+$495,933
-81%
Functional Expenses
Summary
2023
2024
Change
Program
$10,411,098
$9,702,248
-7%
Admin
$1,376,459
$1,871,046
+36%
Fundraising
$2,168,038
$1,856,511
-14%
Total Expenses
$13,955,595
$13,429,805
-4%
Copyright 2026. All rights reserved to Chario Inc. (d.b.a. Impala)